Editing Psoriasis (section)

===Medications===
Drug-induced psoriasis may occur with [[beta blocker]]s,<ref name=Jain2012 /> [[lithium]],<ref name=Jain2012 /> [[antimalarial medication]]s,<ref name=Jain2012 /> [[nonsteroidal anti-inflammatory drug]]s,<ref name=Jain2012 /> [[terbinafine]], [[calcium channel blockers]], [[captopril]], [[glyburide]], [[granulocyte colony-stimulating factor]],<ref name=Jain2012 /> [[interleukin]]s, [[interferon]]s,<ref name=Jain2012 /> [[Hypolipidemic agent|lipid-lowering medications]],<ref name="Andrews"/>{{rp|197}} and paradoxically [[TNF inhibitor]]s such as [[infliximab]] or [[adalimumab]].<ref name="Guerra2013">{{cite journal | vauthors = Guerra I, Gisbert JP | title = Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents | journal = Expert Review of Gastroenterology & Hepatology | volume = 7 | issue = 1 | pages = 41–8 | date = January 2013 | pmid = 23265148 | doi = 10.1586/egh.12.64 | s2cid = 207210831 }}</ref> Withdrawal of [[corticosteroid]]s (topical steroid cream) can aggravate psoriasis due to the [[rebound effect]].<ref name=Weller2008>{{cite book|vauthors=Weller R, Hunter JA, Savin J, Dahl M|title=Clinical dermatology|year=2008|publisher=Blackwell|location=Malden, MA|isbn=978-1-4443-0009-3|pages=54–70|url=https://books.google.com/books?id=5RHM0Nerk9gC&q=dermatology|edition=4th|access-date=19 November 2020|archive-date=24 February 2024|archive-url=https://web.archive.org/web/20240224040825/https://books.google.com/books?id=5RHM0Nerk9gC&q=dermatology|url-status=live}}</ref>